NeoPharm CO., LTD. (092730.KQ)
KRW 12780.0
(-4.91%)
KRW 12780.0
(-4.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 40.07 Billion KRW | 8.39% |
| 2022 | 35.83 Billion KRW | -7.83% |
| 2021 | 38.88 Billion KRW | 9.1% |
| 2020 | 35.63 Billion KRW | -1.87% |
| 2019 | 36.31 Billion KRW | 26.08% |
| 2018 | 28.8 Billion KRW | 11.99% |
| 2017 | 25.72 Billion KRW | 17.82% |
| 2016 | 21.83 Billion KRW | 10.38% |
| 2015 | 19.78 Billion KRW | 0.0% |
| 2014 | 13.74 Billion KRW | N/A |
| 2013 | 12.91 Billion KRW | N/A |
| 2012 | 13.98 Billion KRW | 0.0% |
| 2011 | 11.3 Billion KRW | N/A |
| 2010 | 11.09 Billion KRW | N/A |
| 2009 | 9.73 Billion KRW | N/A |
| 2008 | 6.44 Billion KRW | N/A |
| 2007 | 3.01 Billion KRW | N/A |
| 2006 | 5.67 Billion KRW | N/A |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.06 Billion KRW | -1.36% |
| 2024 Q3 | 21.06 Billion KRW | 2.54% |
| 2024 Q2 | 10.62 Billion KRW | 5.59% |
| 2023 Q1 | 8.98 Billion KRW | -0.09% |
| 2023 Q4 | 10.2 Billion KRW | 8.97% |
| 2023 FY | 38.84 Billion KRW | 8.39% |
| 2023 Q2 | 10.29 Billion KRW | 14.49% |
| 2023 Q3 | 9.36 Billion KRW | -9.04% |
| 2022 Q2 | 9.3 Billion KRW | 4.11% |
| 2022 Q4 | 8.99 Billion KRW | 5.31% |
| 2022 FY | 35.83 Billion KRW | -7.83% |
| 2022 Q3 | 8.54 Billion KRW | -8.21% |
| 2022 Q1 | 8.94 Billion KRW | -16.65% |
| 2021 Q4 | 10.72 Billion KRW | 9.51% |
| 2021 Q3 | 9.79 Billion KRW | 8.67% |
| 2021 FY | 38.88 Billion KRW | 9.1% |
| 2021 Q2 | 9.01 Billion KRW | -3.57% |
| 2021 Q1 | 9.34 Billion KRW | -8.01% |
| 2020 Q2 | 9.98 Billion KRW | 26.97% |
| 2020 FY | 35.63 Billion KRW | -1.87% |
| 2020 Q4 | 10.16 Billion KRW | 12.73% |
| 2020 Q1 | 7.86 Billion KRW | -30.27% |
| 2020 Q3 | 9.01 Billion KRW | -9.69% |
| 2019 FY | 36.31 Billion KRW | 26.08% |
| 2019 Q4 | 11.27 Billion KRW | 30.43% |
| 2019 Q1 | 8.49 Billion KRW | 6.64% |
| 2019 Q2 | 9.39 Billion KRW | 10.63% |
| 2019 Q3 | 8.64 Billion KRW | -7.99% |
| 2018 Q1 | 7.1 Billion KRW | -18.05% |
| 2018 FY | 28.8 Billion KRW | 11.99% |
| 2018 Q3 | 7.21 Billion KRW | 3.17% |
| 2018 Q2 | 6.99 Billion KRW | -1.52% |
| 2018 Q4 | 7.96 Billion KRW | 10.32% |
| 2017 Q1 | 6.08 Billion KRW | -24.92% |
| 2017 FY | 25.72 Billion KRW | 17.82% |
| 2017 Q2 | 6.04 Billion KRW | -0.73% |
| 2017 Q3 | 5.73 Billion KRW | -5.15% |
| 2017 Q4 | 8.66 Billion KRW | 51.18% |
| 2016 Q3 | 4.09 Billion KRW | -13.21% |
| 2016 FY | 21.83 Billion KRW | 10.38% |
| 2016 Q2 | 4.72 Billion KRW | -18.45% |
| 2016 Q4 | 8.1 Billion KRW | 97.84% |
| 2016 Q1 | 5.79 Billion KRW | -43.02% |
| 2015 Q2 | 3.75 Billion KRW | 0.0% |
| 2015 FY | 19.78 Billion KRW | 0.0% |
| 2015 Q3 | 4.01 Billion KRW | 6.76% |
| 2015 Q4 | 10.16 Billion KRW | 153.42% |
| 2013 Q2 | 2.07 Billion KRW | -38.12% |
| 2013 Q1 | 3.35 Billion KRW | -31.9% |
| 2013 Q3 | 2.95 Billion KRW | 42.39% |
| 2012 Q4 | 4.92 Billion KRW | 0.0% |
| 2012 FY | 13.98 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Kolmar BNH Co., Ltd. | 48.54 Billion KRW | 17.44% |